Avian ("Bird") Flu Stocks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avian ("Bird") Flu Stocks

NNVC 2.010

+21.1%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: rrufff	11/18/2005 4:35:07 PM
	Read Replies (1) of 428

AVAN tested resistance at 2, before settling back at 1.82. It's been moving up since indicating it was applying its proprietary vaccine technology to trying to develop a bird flu vaccine. Unlike some other companies, AVAN has a history and strong scientic reputation.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next